The Life Raft Group is pleased to announce the release of the tenth issue of The GIST Cancer Journal, the official journal of the Life Raft Group. The journal is intended to serve as [...]
A recent call to action from ASCO (American Society of Clinical Oncology) published in the Journal of Clinical Oncology recommends expanding clinical trials to include more older adults. Given that greater than 60% of cancers in [...]
The Life Raft Group is pleased to announce the release of the sixth issue of The GIST Cancer Journal, the official journal of the Life Raft Group and the first academic journal devoted solely to GIST. [...]
American Society of Clinical Oncology (ASCO) is planning its first-ever clinical registry study, the Targeted Agent and Profiling Utilization Registry (TAPUR). ASCO plans should increase patient access to off-label drugs and match patients with [...]
At the recent American Society of American Oncology Meeting (ASCO), Dr. George Demetri, Director of the Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, presented results from a collaborative trial that indicates in [...]
Immunotherapy treatments garnered a great deal of attention at the Annual Meeting of the American Society of Clinical Oncology (ASCO). This article from the New York Times discusses this form of treatment and its importance [...]
ASCO was held again this year in Chicago. Over 32,000 medical professionals and exhibitors participated in what has become an international event. 53% of attendees now come from outside the US. It helps to know [...]
ASCO features many updates on GIST trials. Promising results for the immunotherapy approach to treating cancer dominated the annual conference of the ASCO and represent one of the biggest developments in cancer research since the advent [...]
The American Society of Clinical Oncologists (ASCO) and Livestrong Foundation have launched a video on YouTube to promote discussion of fertility preservation in young cancer patients. Keep reading to learn more.
Here is an overview of what Jim Hughes, Pete Knox and Jerry Call learned at ASCO. There will be a more in depth article to come.